Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 250

1.

Placental supernatants' enhancement of the metastatic potential of breast cancer cells: is estrogen receptor (ERα) essential for this phenomenon?

Bar M, Komemi O, Pomeranz M, Fishman A, Drucker L, Lishner M, Tartakover Matalon S.

Arch Gynecol Obstet. 2019 Jul 23. doi: 10.1007/s00404-019-05243-4. [Epub ahead of print]

PMID:
31338656
2.

The Muddied Waters of Ibrutinib Therapy.

Schamroth Pravda M, Schamroth Pravda N, Lishner M.

Acta Haematol. 2019;141(4):209-213. doi: 10.1159/000496555. Epub 2019 Apr 3.

PMID:
30943468
3.

BM-MSCs-derived ECM modifies multiple myeloma phenotype and drug response in a source-dependent manner.

Ibraheem A, Attar-Schneider O, Dabbah M, Dolberg Jarchowsky O, Tartakover Matalon S, Lishner M, Drucker L.

Transl Res. 2019 May;207:83-95. doi: 10.1016/j.trsl.2019.01.003. Epub 2019 Jan 23.

PMID:
30738861
4.

Placenta-conditioned extracellular matrix (ECM) activates breast cancer cell survival mechanisms: A key for future distant metastases.

Komemi O, Shochet GE, Pomeranz M, Fishman A, Pasmanik-Chor M, Drucker L, Matalon ST, Lishner M.

Int J Cancer. 2019 Apr 1;144(7):1633-1644. doi: 10.1002/ijc.31861. Epub 2018 Dec 18.

PMID:
30194759
5.

Mean platelet volume and risk of thrombotic and bleeding complications in patients with Philadelphia chromosome negative myeloproliferative neoplasms.

Krashin E, Cohen O, Pereg D, Lishner M, Leader A.

Blood Coagul Fibrinolysis. 2018 Apr;29(3):288-293. doi: 10.1097/MBC.0000000000000717.

PMID:
29474204
6.

The management of hodgkin lymphomas in pregnancies.

Moshe Y, Bentur OS, Lishner M, Avivi I.

Eur J Haematol. 2017 Nov;99(5):385-391. doi: 10.1111/ejh.12956. Epub 2017 Oct 5. Review.

PMID:
28850718
7.

Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells' phenotype and translation initiation.

Dabbah M, Attar-Schneider O, Tartakover Matalon S, Shefler I, Jarchwsky Dolberg O, Lishner M, Drucker L.

Carcinogenesis. 2017 Jul 1;38(7):708-716. doi: 10.1093/carcin/bgx045.

PMID:
28838065
8.

Clinical, diagnostic, and therapeutic features of patients admitted to acute care hospitals with trunk compared to lower limb cellulitis.

Zalmanovich A, Lishner M, Reisfeld S.

Intern Emerg Med. 2017 Oct;12(7):957-962. doi: 10.1007/s11739-017-1692-y. Epub 2017 Jun 7.

PMID:
28593451
9.

Letter to the Editor: miR-199b-3p and miR-199a-3p are isoforms with identical sequence and established function as tumor and metastasis suppressors.

Dabbah M, Attar-Schneider O, Zismanov V, Tartakover Matalon S, Lishner M, Drucker L.

J Leukoc Biol. 2017 May;101(5):1069. doi: 10.1189/jlb.3LT0117-038. No abstract available.

PMID:
28468983
10.

The Effect of Combined Aspirin and Clopidogrel Treatment on Cancer Incidence.

Leader A, Zelikson-Saporta R, Pereg D, Spectre G, Rozovski U, Raanani P, Hermoni D, Lishner M.

Am J Med. 2017 Jul;130(7):826-832. doi: 10.1016/j.amjmed.2017.01.022. Epub 2017 Feb 14.

PMID:
28213047
11.

Heat shock protein-27 (HSP27) regulates STAT3 and eIF4G levels in first trimester human placenta.

Shochet GE, Komemi O, Sadeh-Mestechkin D, Pomeranz M, Fishman A, Drucker L, Lishner M, Matalon ST.

J Mol Histol. 2016 Dec;47(6):555-563. Epub 2016 Oct 6.

PMID:
27714564
12.

Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation.

Dabbah M, Attar-Schneider O, Zismanov V, Tartakover Matalon S, Lishner M, Drucker L.

J Leukoc Biol. 2016 Oct;100(4):761-770. Epub 2016 Jun 6.

PMID:
27272311
13.

Mesenchymal stem cells secretomes' affect multiple myeloma translation initiation.

Marcus H, Attar-Schneider O, Dabbah M, Zismanov V, Tartakover-Matalon S, Lishner M, Drucker L.

Cell Signal. 2016 Jun;28(6):620-30. doi: 10.1016/j.cellsig.2016.03.003. Epub 2016 Mar 11.

PMID:
26976208
14.

First trimester human placenta prevents breast cancer cell attachment to the matrix: The role of extracellular matrix.

Epstein Shochet G, Drucker L, Pomeranz M, Fishman A, Pasmanik-Chor M, Tartakover-Matalon S, Lishner M.

Mol Carcinog. 2017 Jan;56(1):62-74. doi: 10.1002/mc.22473. Epub 2016 Feb 9.

PMID:
26859229
15.

Hematologic Malignancies in Pregnancy: Management Guidelines From an International Consensus Meeting.

Lishner M, Avivi I, Apperley JF, Dierickx D, Evens AM, Fumagalli M, Nulman I, Oduncu FS, Peccatori FA, Robinson S, Van Calsteren K, Vandenbroucke T, Van den Heuvel F, Amant F.

J Clin Oncol. 2016 Feb 10;34(5):501-8. doi: 10.1200/JCO.2015.62.4445. Epub 2015 Nov 30.

16.

[THE EFFECT OF PREGNANCY ON BREAST CANCER].

Matalon ST, Shochet GE, Drucker L, Lishner M.

Harefuah. 2015 Aug;154(8):530-4, 539. Review. Hebrew.

PMID:
26480621
17.

[THE EFFECT OF PLACENTAL SOLUBLE FACTORS AND STEROID HORMONES ON OVARIAN CANCER PHENOTYPE].

Amitai I, Matalon ST, Shochet GE, Drucker L, Pomeranz M, Fishman A, Lishner M.

Harefuah. 2015 Aug;154(8):485-9, 542. Hebrew.

PMID:
26480610
18.

Multiple myeloma and bone marrow mesenchymal stem cells' crosstalk: Effect on translation initiation.

Attar-Schneider O, Zismanov V, Dabbah M, Tartakover-Matalon S, Drucker L, Lishner M.

Mol Carcinog. 2016 Sep;55(9):1343-54. doi: 10.1002/mc.22378. Epub 2015 Aug 21.

PMID:
26293751
19.

[SECONDARY PREVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME HOSPITALIZED IN INTERNAL MEDICINE DEPARTMENTS].

Yahia DH, Pereg D, Lishner M, Elis A.

Harefuah. 2015 May;154(5):299-302, 339-40. Hebrew.

PMID:
26168639
20.

Candida albicans in peritoneal fluid in a patient with hepatic encephalopathy.

Krashin E, Lishner M, Chowers M, Reisfeld S.

Isr Med Assoc J. 2015 Mar;17(3):193-4. No abstract available.

21.

eIF4E and eIF4GI have distinct and differential imprints on multiple myeloma's proteome and signaling.

Attar-Schneider O, Pasmanik-Chor M, Tartakover-Matalon S, Drucker L, Lishner M.

Oncotarget. 2015 Feb 28;6(6):4315-29.

22.

First trimester human placental factors induce breast cancer cell autophagy.

Epstein Shochet G, Drucker L, Pasmanik-Chor M, Pomeranz M, Fishman A, Tartakover Matalon S, Lishner M.

Breast Cancer Res Treat. 2015 Feb;149(3):645-54. doi: 10.1007/s10549-015-3266-x. Epub 2015 Feb 6.

PMID:
25656679
23.

Candida albicans in peritoneal fluid in a patient with hepatic encephalopathy.

Krashin E, Lishner M, Chowers M, Reisfeld S.

Isr Med Assoc J. 2014 Dec;16(12):801-2. No abstract available.

24.

Multiple myeloma proteostasis can be targeted via translation initiation factor eIF4E.

Zismanov V, Attar-Schneider O, Lishner M, Heffez Aizenfeld R, Tartakover Matalon S, Drucker L.

Int J Oncol. 2015 Feb;46(2):860-70. doi: 10.3892/ijo.2014.2774. Epub 2014 Nov 24.

PMID:
25422161
25.

Placenta-breast cancer cell interactions promote cancer cell epithelial mesenchymal transition via TGFβ/JNK pathway.

Epstein Shochet G, Tartakover-Matalon S, Drucker L, Pasmanik-Chor M, Pomeranz M, Fishman A, Lishner M.

Clin Exp Metastasis. 2014 Dec;31(8):961-75. doi: 10.1007/s10585-014-9683-0. Epub 2014 Oct 15.

PMID:
25316285
26.

Thyrotropin levels within the lower normal range are associated with an increased risk of hip fractures in euthyroid women, but not men, over the age of 65 years.

Leader A, Ayzenfeld RH, Lishner M, Cohen E, Segev D, Hermoni D.

J Clin Endocrinol Metab. 2014 Aug;99(8):2665-73. doi: 10.1210/jc.2013-2474. Epub 2014 Jun 2.

PMID:
24885627
27.

Targeting eIF4GI translation initiation factor affords an attractive therapeutic strategy in multiple myeloma.

Attar-Schneider O, Drucker L, Zismanov V, Tartakover-Matalon S, Lishner M.

Cell Signal. 2014 Sep;26(9):1878-87. doi: 10.1016/j.cellsig.2014.05.005. Epub 2014 May 9.

PMID:
24815186
28.

Can flow cytometry of bone marrow aspirate predict outcome of patients with diffuse large B cell lymphoma? A retrospective single centre study.

Wolach O, Fraser A, Luchiansky M, Shapiro C, Radnay J, Shpilberg O, Lishner M, Lahav M.

Hematol Oncol. 2015 Mar;33(1):42-7. doi: 10.1002/hon.2127. Epub 2014 Jan 27.

PMID:
24470400
29.

Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting.

Amant F, Halaska MJ, Fumagalli M, Dahl Steffensen K, Lok C, Van Calsteren K, Han SN, Mir O, Fruscio R, Uzan C, Maxwell C, Dekrem J, Strauven G, Mhallem Gziri M, Kesic V, Berveiller P, van den Heuvel F, Ottevanger PB, Vergote I, Lishner M, Morice P, Nulman I; ESGO task force ‘Cancer in Pregnancy’.

Int J Gynecol Cancer. 2014 Mar;24(3):394-403. doi: 10.1097/IGC.0000000000000062. Review. Erratum in: Int J Gynecol Cancer. 2014 May;24(4):819.

PMID:
24445819
30.

The effect of heat shock protein 27 on extravillous trophoblast differentiation and on eukaryotic translation initiation factor 4E expression.

Sadeh-Mestechkin D, Epstein Shochet G, Pomeranz M, Fishman A, Drucker L, Biron-Shental T, Lishner M, Tartakover Matalon S.

Mol Hum Reprod. 2014 May;20(5):422-32. doi: 10.1093/molehr/gau002. Epub 2014 Jan 14.

PMID:
24431103
31.

Lipid control in patients with coronary heart disease treated in primary care or cardiology clinics.

Pereg D, Elis A, Neuman Y, Mosseri M, Leader A, Segev D, Granek-Catarivas M, Lishner M, Hermoni D.

J Clin Lipidol. 2013 Nov-Dec;7(6):637-41. doi: 10.1016/j.jacl.2013.06.005. Epub 2013 Jun 18.

PMID:
24314362
32.

Comparison of mortality in patients with coronary or peripheral artery disease following the first vascular intervention.

Pereg D, Elis A, Neuman Y, Mosseri M, Segev D, Granek-Catarivas M, Lishner M, Hermoni D.

Coron Artery Dis. 2014 Jan;25(1):79-82. doi: 10.1097/MCA.0000000000000044.

PMID:
24128887
33.

Comparison of lipid control in patients with coronary versus peripheral artery disease following the first vascular intervention.

Pereg D, Neuman Y, Elis A, Minha S, Mosseri M, Segev D, Lishner M, Hermoni D.

Am J Cardiol. 2012 Nov 1;110(9):1266-9. doi: 10.1016/j.amjcard.2012.06.030. Epub 2012 Jul 21.

PMID:
22819425
34.

The involvement of eukaryotic translation initiation factor 4E in extravillous trophoblast cell function.

Kitroser E, Pomeranz M, Epstein Shochet G, Fishman A, Drucker L, Sadeh-Mestechkin D, Lishner M, Tartakover-Matalon S.

Placenta. 2012 Sep;33(9):717-24. doi: 10.1016/j.placenta.2012.06.004. Epub 2012 Jun 29.

PMID:
22748716
35.

Unrecognized renal insufficiency and chemotherapy-associated adverse effects among breast cancer patients.

Lotan E, Leader A, Lishner M, Gottfried M, Pereg D.

Anticancer Drugs. 2012 Oct;23(9):991-5. doi: 10.1097/CAD.0b013e328355dd8a.

PMID:
22728764
36.

Non-every day statin administration--a literature review.

Elis A, Lishner M.

Eur J Intern Med. 2012 Jul;23(5):474-8. doi: 10.1016/j.ejim.2012.02.006. Epub 2012 Mar 16. Review.

PMID:
22726380
37.

Mortality and coronary heart disease in euthyroid patients.

Pereg D, Tirosh A, Elis A, Neuman Y, Mosseri M, Segev D, Lishner M, Hermoni D.

Am J Med. 2012 Aug;125(8):826.e7-12. doi: 10.1016/j.amjmed.2011.11.023. Epub 2012 May 16.

38.

Tetraspanins stimulate protein synthesis in myeloma cell lines.

Zismanov V, Drucker L, Attar-Schneider O, Matalon ST, Pasmanik-Chor M, Lishner M.

J Cell Biochem. 2012 Jul;113(7):2500-10. doi: 10.1002/jcb.24126.

PMID:
22415769
39.

Are platelet volume indices of clinical use? A multidisciplinary review.

Leader A, Pereg D, Lishner M.

Ann Med. 2012 Dec;44(8):805-16. doi: 10.3109/07853890.2011.653391. Epub 2012 Mar 13. Review.

PMID:
22413913
40.

Haematological cancers in pregnancy.

Brenner B, Avivi I, Lishner M.

Lancet. 2012 Feb 11;379(9815):580-7. doi: 10.1016/S0140-6736(11)61348-2. Review.

PMID:
22325663
41.

Bevacizumab attenuates major signaling cascades and eIF4E translation initiation factor in multiple myeloma cells.

Attar-Schneider O, Drucker L, Zismanov V, Tartakover-Matalon S, Rashid G, Lishner M.

Lab Invest. 2012 Feb;92(2):178-90. doi: 10.1038/labinvest.2011.162. Epub 2011 Nov 14.

42.

Hormone-dependent placental manipulation of breast cancer cell migration.

Epstein Shochet G, Tartakover Matalon S, Drucker L, Pomeranz M, Fishman A, Rashid G, Oron-Karni V, Pasmanik-Chor M, Lishner M.

Hum Reprod. 2012 Jan;27(1):73-88. doi: 10.1093/humrep/der365. Epub 2011 Nov 2.

PMID:
22048988
43.

HDL-C levels and revascularization procedures in coronary heart disease patients treated with statins to target LDL-C levels.

Elis A, Pereg D, Froom P, Lishner M, Segev D, Hermoni D.

Clin Cardiol. 2011 Sep;34(9):572-6. doi: 10.1002/clc.20944. Epub 2011 Sep 1.

44.

High-dose imatinib for newly diagnosed chronic phase chronic myeloid leukemia patients--systematic review and meta-analysis.

Gafter-Gvili A, Leader A, Gurion R, Vidal L, Ram R, Shacham-Abulafia A, Ben-Bassat I, Lishner M, Shpilberg O, Raanani P.

Am J Hematol. 2011 Aug;86(8):657-62. doi: 10.1002/ajh.22076. Review.

45.

[The new anticoagulants].

Nemets A, Lishner M, Lugassy G.

Harefuah. 2011 May;150(5):458-62, 490. Review. Hebrew.

PMID:
21678643
46.

The achievement of target cholesterol level differs between coronary heart disease and diabetic patients.

Elis A, Chodick G, Heymann AD, Kokia E, Flash S, Lishner M, Shalev V.

Eur J Intern Med. 2011 Jun;22(3):262-5. doi: 10.1016/j.ejim.2011.02.020. Epub 2011 Mar 26.

PMID:
21570645
47.

Leukemia and lymphoma in pregnancy.

Abadi U, Koren G, Lishner M.

Hematol Oncol Clin North Am. 2011 Apr;25(2):277-91, vii. doi: 10.1016/j.hoc.2011.01.001. Review.

PMID:
21444030
48.

Managing statin-induced muscle toxicity in a lipid clinic.

Blaier O, Lishner M, Elis A.

J Clin Pharm Ther. 2011 Jun;36(3):336-41. doi: 10.1111/j.1365-2710.2011.01254.x. Epub 2011 Mar 18.

PMID:
21414023
49.

Fertility considerations and preservation in haemato-oncology patients undergoing treatment.

Leader A, Lishner M, Michaeli J, Revel A.

Br J Haematol. 2011 May;153(3):291-308. doi: 10.1111/j.1365-2141.2011.08629.x. Epub 2011 Mar 9. Review.

PMID:
21391973
50.

Pregnancy and commonly used drugs in hematology practice.

Koren G, Lishner M.

Hematology Am Soc Hematol Educ Program. 2010;2010:160-5. doi: 10.1182/asheducation-2010.1.160.

PMID:
21239787

Supplemental Content

Loading ...
Support Center